Equity ETFs Very High Risk
The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the Constituents of S&P BSE Healthcare Index, subject to tracking error.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
Expert-managed portfolios tailored to your financial goals.
Estimation is based on the past performance
| ETFs | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | 6.77% | 7.99% | -0.5% | -2.64% | 6% | 12.56% | 24.95% | 0% | 0% | 0% | 19.82% |
| Category returns | 10.45% | -1.93% | -3.95% | 0.33% | 4.72% | 4.18% | 14.82% | 12.21% | 13.25% | 13.57% | N/A |
| Absolute returns | 9.13% | 10.67% | 5.73% | 6.2% | 11.19% | 34.92% | 104.86% | 0% | 0% | 0% | 108.59% |
| Rank within category | 215 | 13 | 54 | 128 | 68 | 2 | 9 | 97 | 74 | 38 | N/A |
| Total Schemes in Category | 240 | 228 | 208 | 196 | 180 | 143 | 123 | 96 | 73 | 37 | N/A |
| ETFs | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Yearly returns | N/A | 37.59% | 43.8% | -2.93% | 7.81% |
| Q1 returns | N/A | -4.83% | 11.2% | -8.4% | -4.53% |
| Q2 returns | N/A | 17.95% | 5.84% | 6.89% | 12.93% |
| Q3 Returns | N/A | 10.76% | 19.44% | -2.47% | N/A |
| Q4 Returns | -1.34% | 10.66% | 2.3% | 1.66% | N/A |
Expense ratio: 0.26%
Inclusive of GST
Exit load
| Alpha | 1.18317 |
| Beta | 0.7375 |
| Sharpe Ratio | 0.359401 |
| Sortino Ratio | 0.794617 |
| R-Squared | 0.3653 |
| Tracking Error | 3.518 |
| Downside Risk | 16.9168 |
| Std. Deviation (Annualised) | 14.7772 |
| ETFs | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Expense Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CPSE Exchange Traded Scheme | 8.04% | 10.23% | 14.21% | 18.45% | 21.52% | 37.46% | 36.12% | 18.4% | 16.27% | 20,592.20 | 0.07 | 0.41 | Very High |
| Motilal Oswal BSE Enhanced Value ETF | 11.01% | -2.09% | 4.12% | 14.4% | 19.73% | 32.1% | 0% | 0% | 33.41% | 146.76 | 0.35 | 0.37 | Very High |
| ICICI Prudential Nifty PSU Bank ETF | 7.7% | -6.04% | 5.12% | 22.51% | 29.97% | 27.07% | 0% | 0% | 31.46% | 110.26 | 0.40 | 0.30 | Very High |
| Kotak Nifty PSU Bank ETF | 7.69% | -6.06% | 5.06% | 22.41% | 29.83% | 26.88% | 33.26% | 13.6% | 6.64% | 2,148.17 | 0.49 | 0.30 | Very High |
| Nippon India ETF Nifty PSU Bank BeES | 7.69% | -6.06% | 5.06% | 22.41% | 29.83% | 26.86% | 33.28% | 13.65% | 7.22% | 3,670.36 | 0.49 | 0.29 | Very High |
| ICICI Prudential Nifty Auto ETF | 9.02% | -2.99% | -3.3% | 9.51% | 17.11% | 25.98% | 0% | 0% | 21.22% | 162.29 | 0.20 | 0.32 | Very High |
| Nippon India Nifty Auto ETF | 9.01% | -3.01% | -3.36% | 9.44% | 17.03% | 25.89% | 0% | 0% | 22.34% | 384.16 | 0.22 | 0.32 | Very High |
| Bharat 22 ETF | 9.17% | 2.93% | 6.44% | 14.88% | 17.25% | 25.74% | 28.34% | 0% | 15.83% | 9,797.37 | 0.07 | 0.34 | Very High |
| Motilal Oswal BSE Healthcare ETF Current | 6.77% | 7.99% | -0.5% | -2.64% | 6% | 24.95% | 0% | 0% | 19.82% | 40.68 | 0.24 | 0.35 | Very High |
| Motilal Oswal Nifty Midcap 100 ETF | 13.55% | 2.44% | -0.3% | 3.5% | 11.02% | 24.03% | 20.52% | 16.7% | 14.72% | 726.57 | 0.23 | 0.30 | Very High |
| Instrument Allocation | Instrument | Assets % |
|---|---|---|
|
|
Domestic Equities | 99.88% |
| Cash & Cash Equivalents and Net Assets | 0.12% | |
| Others | 0.00% |
| Sector Allocation | Sector | Assets % |
|---|---|---|
| Pharmaceuticals & Biotechnology | 75.96% | |
| Healthcare Services | 23.38% | |
| Healthcare Equipment & Supplies | 0.55% | |
| Others | 0.12% |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 13.90% |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 5.90% |
| Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 5.74% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 5.55% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 5.28% |
| Max Healthcare Institute Ltd. | Healthcare Services | Domestic Equities | 5.23% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.97% |
| Fortis Healthcare Ltd. | Healthcare Services | Domestic Equities | 3.43% |
| Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.04% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.03% |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.76% |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.56% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.25% |
| Biocon Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.87% |
| Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.78% |
| Zydus Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.60% |
| Ipca Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.52% |
| Aster DM Healthcare Ltd. | Healthcare Services | Domestic Equities | 1.32% |
| JB Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.22% |
| Krishna Institute of Medical Sciences Ltd | Healthcare Services | Domestic Equities | 1.18% |
| Sai Life Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.03% |
| Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.99% |
| Acutaas Chemicals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.95% |
| Abbott India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.92% |
| Neuland Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.92% |
| Narayana Hrudayalaya Ltd. | Healthcare Services | Domestic Equities | 0.87% |
| Ajanta Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.85% |
| Wockhardt Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.82% |
| Dr. Lal Pathlabs Ltd. | Healthcare Services | Domestic Equities | 0.75% |
| Granules India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.73% |
| Piramal Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.71% |
| Natco Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.70% |
| Onesource Specialty Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.68% |
| Glaxosmithkline Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.68% |
| Global Health Ltd. | Healthcare Services | Domestic Equities | 0.66% |
| Syngene International Ltd. | Healthcare Services | Domestic Equities | 0.63% |
| Eris Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.58% |
| Cohance Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.55% |
| Jubilant Pharmova Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.53% |
| Pfizer Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.51% |
| Strides Pharma Science Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.49% |
| Rainbow Children's Medicare Ltd. | Healthcare Services | Domestic Equities | 0.45% |
| Poly Medicure Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 0.41% |
| Emcure Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.41% |
| Vijaya Diagnostic Centre Ltd. | Healthcare Services | Domestic Equities | 0.39% |
| Astrazeneca Pharma India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.37% |
| Indegene Ltd. | Healthcare Services | Domestic Equities | 0.36% |
| Metropolis Healthcare Ltd. | Healthcare Services | Domestic Equities | 0.36% |
| Shilpa Medicare Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.34% |
| Anthem Biosciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.33% |
| Marksans Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.33% |
| Jupiter Life Line Hospitals Ltd. | Healthcare Services | Domestic Equities | 0.33% |
| Alembic Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.30% |
| Procter & Gamble Health Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.29% |
| Aarti Pharmalabs Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.27% |
| Concord Biotech Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.27% |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare Services | Domestic Equities | 0.25% |
| Caplin Point Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.24% |
| Dr. Agarwal's Health Care Ltd. | Healthcare Services | Domestic Equities | 0.24% |
| Alivus Life Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.23% |
| Sanofi Consumer Healthcare India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.23% |
| Viyash Scientific Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.22% |
| Healthcare Global Enterprises Ltd. | Healthcare Services | Domestic Equities | 0.22% |
| Sanofi India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.22% |
| Kovai Medical Center & Hospital Ltd. | Healthcare Services | Domestic Equities | 0.19% |
| Thyrocare Technologies Ltd. | Healthcare Services | Domestic Equities | 0.18% |
| Rubicon Research Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.17% |
| Senores Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.16% |
| Akums Drugs & Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.14% |
| Bliss GVS Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.13% |
| Supriya Lifescience Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.13% |
| FDC Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.13% |
| Indraprastha Medical Corporation Ltd. | Healthcare Services | Domestic Equities | 0.13% |
| Net Receivables / (Payables) | Cash & Cash Equivalents and Net Assets | 0.12% | |
| Advanced Enzyme Technologies Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.12% |
| Blue Jet Healthcare Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.11% |
| Morepen Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.10% |
| Suven Life Sciences Ltd. | Healthcare Services | Domestic Equities | 0.10% |
| Sun Pharma Advanced Research Company Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.10% |
| Aarti Drugs Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.09% |
| Innova Captab Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.09% |
| Artemis Medicare Services Ltd. | Healthcare Services | Domestic Equities | 0.09% |
| IOL Chemicals And Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.08% |
| Dishman Carbogen Amcis Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.08% |
| SMS Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.08% |
| Gujarat Themis Biosyn Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.08% |
| Solara Active Pharma Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.08% |
| Krsnaa Diagnostics Ltd. | Healthcare Services | Domestic Equities | 0.08% |
| RPG Life Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.07% |
| Orchid Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.07% |
| Fischer Medical Ventures Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 0.07% |
| Park Medi World Ltd. | Healthcare Services | Domestic Equities | 0.06% |
| Nephrocare Health Services Ltd. | Healthcare Services | Domestic Equities | 0.06% |
| Unichem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.06% |
| Indoco Remedies Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.06% |
| Gufic Biosciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.05% |
| CORONA Remedies Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.05% |
| Novartis India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.05% |
| Kwality Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.05% |
| Hikal Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.05% |
| Vimta Labs Ltd. | Healthcare Services | Domestic Equities | 0.05% |
| Windlas Biotech Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.05% |
| Syncom Formulations (India) Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.05% |
| Hester Biosciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.04% |
| Lincoln Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.04% |
| 3B Blackbio Dx Ltd. | Healthcare Services | Domestic Equities | 0.04% |
| Panacea Biotec Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.04% |
| Dr Agarwals Eye Hospital Ltd. | Healthcare Services | Domestic Equities | 0.04% |
| Suraksha Diagnostic Ltd. | Healthcare Services | Domestic Equities | 0.04% |
| Wanbury Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.04% |
| Shalby Ltd. | Healthcare Services | Domestic Equities | 0.03% |
| Kopran Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.03% |
| Bajaj Healthcare Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.03% |
| Sigachi Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.03% |
| Jagsonpal Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.03% |
| GPT Healthcare Ltd. | Healthcare Services | Domestic Equities | 0.03% |
| Laxmi Dental Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 0.03% |
| KMC Speciality Hospitals (India) Ltd. | Healthcare Services | Domestic Equities | 0.02% |
| Tarsons Products Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 0.02% |
| Fermenta Biotech Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.02% |
| Themis Medicare Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.02% |
| Anuh Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.02% |
| Health X Platform Ltd. | Healthcare Services | Domestic Equities | 0.02% |
| Fabtech Technologies Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 0.01% |
| Shree Ganesh Remedies Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.01% |
| Gujarat Kidney And Super Speciality Ltd. | Healthcare Services | Domestic Equities | 0.01% |
| Nectar Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.01% |
| Dr. Reddy's Laboratories Ltd. | Others | 0.00% | |
| Total | 100.00% |
RETURNS
It is an Open ended scheme that primarily invests in ETFs.
The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the Constituents of S&P BSE Healthcare Index, subject to tracking error.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
The scheme benchmark is the BSE Health Care - TRI
It is classified as Very High Risk, suitable for investors with a Very High risk appetite.
Returns Delivered by the funds are as follows:
1-year: 11.19%
3-year: 26.98%
5-year: 0%
Top holdings include names such as:
The NAV is around ₹47.77 (approx.) for the Motilal Oswal BSE Healthcare ETF.
The fund’s AUM is approximately ₹42 Cr.
The expense ratio for the Regular Plan is 0.26.
.
Minimum SIP starts at ₹0.
The minimum lump sum investment is ₹500. Often platforms may require higher in practice, but the statutory minimum remains the same.
You can start a SIP through:
Broker/agent platform like Sharescart.
Enter KYC details, choose the Regular Growth option, set SIP amount/frequency, and submit.
Yes. You can modify your SIP amount or frequency anytime online through the Sharescart platform.
You can redeem online via the Sharescart platform — choose the scheme, select the amount/units, and submit. Proceeds are credited to your bank account.
The fund managers: Swapnil P Mayekar, Dishant Mehta, Rakesh Shetty
This fund is suitable for investors with a Very High risk tolerance.
Get personalized Portfolio Management Services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
